Comparison of double disc and three dimensional methods to screen for ESBL producers in a tertiary care hospital

Menon, T.; Bindu, D.; Kumar, C. P. G.; Nalini, S.; Thirunarayan, M. A.
April 2006
Indian Journal of Medical Microbiology;Apr2006, Vol. 24 Issue 2, p117
Academic Journal
journal article
Extended spectrum beta lactamases (ESBLs) continue to be a major problem in clinical setups world over, conferring resistance to the expanded spectrum cephalosporins. An attempt was made to study ESBL production among Enterobacteriaceae members from a tertiary care center in Chennai. A total of seventy randomly collected isolates of the family Enterobacteriaceae from a tertiary care center was studied for their susceptibility patterns to various antibiotics and detection of ESBL producers by double disc synergy (DDS) test and three dimensional test (TDT). Eighty percent of the isolates were multidrug resistant (MDR) and 20% were ESBL producers. TDT detected 85.7% whereas only 14.2% were detected by DDS. In the present study, a large number of isolates were found to be MDR and ESBL producers. TDTs were found to be better than DDS in the detection of ESBLs. Continued monitoring of drug resistance is necessary in clinical settings for proper disease management.


Related Articles

  • Hospital-Based Strategies for Combating Resistance. Owens, Jr., Robert C.; Rice, Louis // Clinical Infectious Diseases;4/15/2006 Supplement, Vol. 42, pS173 

    Selective pressures generated by the indiscriminate use of β-lactam antibiotics have resulted in increased bacterial resistance across all β-lactams classes. In particular, the use of third-generation cephalosporins has been associated with the emergence of extended-spectrum...

  • Structural studies of the mechanism for biosensing antibiotics in a fluoresceinlabeled βlactamase. Wai-Ting Wong; Ho-Wah Au; Hong-Kin Yap; Yun-Chung Leung; Kwok-Yin Wong; Yanxiang Zhao // BMC Structural Biology;2011, Vol. 11 Issue 1, p15 

    Background: β-lactamase conjugated with environment-sensitive fluorescein molecule to residue 166 on the ∩-loop near its catalytic site is a highly effective biosensor for β-lactam antibiotics. Yet the molecular mechanism of such fluorescence-based biosensing is not well understood....

  • Baxan.  // Royal Society of Medicine: Medicines;2002, p99 

    The article presents information on baxan which is a proprietary, prescription-only preparation of the antibacterial and (cephalosporin) antibiotic cefadroxil. It can be used to treat many infections, and is available as capsules and an oral suspension.

  • Enhanced production of penicillin G acylase from a recombinant Escherichia coli. Vohra, Pawan Kumar; Sharma, Rakesh; Raj Kashyap, Des; Tewari, Rupinder // Biotechnology Letters;Apr2001, Vol. 23 Issue 7, p531 

    Penicillin G acylase (pac) gene was cloned into a stable asd+ vector (pYA292) and expressed in Escherichia coli. This recombinant strain produced 1000 units penicillin G acylase g-1 cell dry wt, which is 23-fold more than that produced by parental Escherichia coli ATCC11105. This enzyme was...

  • Commentary: A step forward in the everyday management of adults with community acquired pneumonia. Woodhead, Mark; Verheij, Theo J. M. // BMJ: British Medical Journal (International Edition);2/26/2005, Vol. 330 Issue 7489, p460 

    Comments on the study in this issue concerning the everyday management of adults with community acquired pneumonia. Belief the study should reassure all health professional that therapy using lactam antibiotics, macrolide of flurorquinolones is equally effective when judged by clinical cure and...

  • Resistance to Third-Generation Cephalosporins and Other Antibiotics by Enterobacteriaceae in Western Nigeria. Okesola, A. O.; Makanjuola, O. // American Journal of Infectious Diseases;2009, Vol. 5 Issue 1, p17 

    Problem statement: The emergence and spread of resistance to third-generation cephalosporins are threatening to create species resistant to all currently available agents. The most common cause of bacterial resistance to beta-lactam antibiotics is the production of beta-lactamases and many of...

  • Activity of chequerboard combinations of ceftaroline and NXL104 versus β-lactamase-producing Enterobacteriaceae. Mushtaq, S.; Warner, M.; Williams, G.; Critchley, I.; Livermore, D. M. // Journal of Antimicrobial Chemotherapy (JAC);Jul2010, Vol. 65 Issue 7, p1428 

    Background: Ceftaroline is a novel oxyimino-cephalosporin, strongly active against methicillin-resistant staphylococci and pneumococci. It is active against Enterobacteriaceae too, but is labile to common β-lactamases, including AmpC and extended-spectrum types. To counteract these enzymes,...

  • When to use the newer beta-lactam antibiotics. Rosenfeld, Elaine; Shaughnessy, Allen F. // Patient Care;9/15/1995, Vol. 29 Issue 14, p119 

    Studies the use of the new beta-lactam antibiotics and some third generation cephalosporin drugs. Brief on the fungus Cephalosporium acremonium; Description of oral agents Cefixime, Cefpodoxime proxetil, Cefprozil and Loracarbef, and parental agents Ceftazidine, Aztreonam, Imipenem/cilastatin...

  • Clinical Use of the New Beta--Lactam Antimicrobial Drugs. Brooks, Geo F.; Barriere, Steven L. // Annals of Internal Medicine;Apr83, Vol. 98 Issue 4, p530 

    Discusses the clinical use of beta-lactam antimicrobial drugs. Cost-benefit considerations; Results of clinical microbiology laboratory and susceptibility testing; Guidelines for evaluation and use of the antimicrobial agents.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics